Evaluating vaccines for HIV prevention using nonhuman primates
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
['FUNDING_OTHER'] · BIOQUAL, INC. · NIH-10138755
This study is working on creating better vaccines and prevention methods for HIV by testing them in nonhuman primates, which helps researchers learn how to protect people from the virus.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BIOQUAL, INC. (nih funded) |
| Locations | 1 site (ROCKVILLE, UNITED STATES) |
| Trial ID | NIH-10138755 on ClinicalTrials.gov |
What this research studies
This research focuses on the development and evaluation of effective HIV vaccines and prevention strategies through the use of nonhuman primates (NHPs). The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for preclinical studies, allowing researchers to assess candidate AIDS vaccines and their ability to generate immune responses. The program supports various stages of vaccine research, including testing vaccine efficacy and identifying factors that enhance immune protection against HIV. By utilizing NHP models, the research aims to improve our understanding of how to prevent or control HIV infection in humans.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at high risk for HIV who may eventually receive effective vaccines developed through these studies.
Not a fit: Patients who are already living with HIV or those who do not have access to future vaccine options may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that significantly reduce the risk of HIV infection in humans.
How similar studies have performed: Previous research using nonhuman primates for HIV vaccine evaluation has shown promise, indicating that this approach is both tested and has the potential for significant breakthroughs.
Where this research is happening
ROCKVILLE, UNITED STATES
- BIOQUAL, INC. — ROCKVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEWIS, MARK — BIOQUAL, INC.
- Study coordinator: LEWIS, MARK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.